Tuesday, May 16 2023
09:35 AM – 09:55 AM PT
CD19-palooza: Summary of indications and factors impacting outcomes
Michael D.. Jain. Moffitt Cancer Center, Tampa, FL
Disclosures: M.D. Jain: 1; Commercial Interest i.e. Company X; Kite/Gilead. 1; What was received? i.e. Honorarium; Consultancy/Advisory; Research Funding. 2; Commercial Interest i.e. Company X; Novartis. 2; What was received? i.e. Honorarium; Consultancy/Advisory. 3; Commercial Interest i.e. Company X; BMS. 3; What was received? i.e. Honorarium; Consultancy/Advisory. 4; Commercial Interest i.e. Company X; Myeloid Therapeutics. 4; What was received? i.e. Honorarium; Consultancy/Advisory. 5; Commercial Interest i.e. Company X; Incyte. 5; What was received? i.e. Honorarium; Research Funding.